WHO ICTRP trial
Efficacy and tolerance of tazarotene cream in lamellar ichthyosis (LI): a…
ISRCTN86666250 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN86666250 |
|---|---|
| Public title | Efficacy and tolerance of tazarotene cream in lamellar ichthyosis (LI): a dose-finding study |
| Primary sponsor | Orfagen (France) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | France;Germany |
| Conditions | Non Erythrodermic Autosomic Recessive Lamellar Ichthyosis (NEARLI) Not Applicable Congenital ichthyosis |
| Interventions | Study treatments: Tazarotene cream 0.1% or 0.05% and vehicle. Dose: Period I (4 weeks): Patients will apply one of the two active test products and the vehicle on the lesions (except on face, scalp, neck and genital areas), on two randomly… |
| Registration date | Feb 14, 2008 |
| Target size | 30 |
| Secondary IDs | R00002 CR 2 01 (ORF) |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: